Bristol Myers Squibb to Participate in Wolfe Research's 2nd Annual Virtual Healthcare Conference Biotech Investing
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Pharmaceutical Investing
Perimeter Medical Imaging AI to Present at Upcoming Virtual Investor Conferences Medical Device Investing
Bristol Myers Squibb Showcases Research Advancing Outcomes Addressing Hard-to-Treat Blood Cancers and Diseases Across Small Molecule, Biologic and Cell Therapies at ASH 2020 Biotech Investing
Pfizer Announces Positive Results from Fifth Phase 3 Trial of Abrocitinib, Evaluating Safety and Efficacy Across Different Dosing Regimens Pharmaceutical Investing
Pfizer and BioNTech Reach an Agreement to Supply the EU With 200 Million Doses of Their BNT162b2 mRNA-Based Vaccine Candidate Against SARS-CoV-2 Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
